Maven Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.1M Sell
20,800
-19,900
-49% -$20.2M 0.37% 63
2025
Q4
$43.8M Sell
40,700
-20,600
-34% -$19.7M 0.97% 25
2025
Q3
$46.8M Buy
61,300
+52,400
+589% +$39M 1.16% 14
2025
Q2
$6.94M Sell
8,900
-6,000
-40% -$4.66M 0.17% 139
2025
Q1
$12.3M Buy
14,900
+4,600
+45% +$3.83M 0.38% 60
2024
Q4
$7.95M Buy
10,300
+6,400
+164% +$5.3M 0.19% 94
2024
Q3
$3.46M Sell
3,900
-2,900
-43% -$2.61M 0.07% 255
2024
Q2
$6.16M Buy
+6,800
New +$5.44M 0.14% 153
2024
Q1
Sell
-3,000
Closed -$1.75M 704
2023
Q4
$1.75M Sell
3,000
-13,700
-82% -$8M 0.04% 342
2023
Q3
$8.97M Sell
16,700
-100
-0.6% -$51.5K 0.1% 108
2023
Q2
$7.88M Buy
16,800
+15,600
+1,300% +$6.54M 0.12% 93
2023
Q1
$412K Sell
1,200
-600
-33% -$202K 0.01% 710
2022
Q4
$659K Sell
1,800
-5,800
-76% -$2.06M 0.01% 514
2022
Q3
$2.46M Buy
7,600
+5,700
+300% +$1.81M 0.05% 263
2022
Q2
$616K Buy
1,900
+400
+27% +$120K 0.02% 514
2022
Q1
$430K Sell
1,500
-3,500
-70% -$901K 0.02% 586
2021
Q4
$1.38M Sell
5,000
-3,200
-39% -$811K 0.04% 265
2021
Q3
$1.9M Buy
8,200
+6,800
+486% +$1.68M 0.06% 260
2021
Q2
$321K Sell
1,400
-3,500
-71% -$703K 0.01% 810
2021
Q1
$915K Buy
+4,900
New +$958K 0.04% 455
2020
Q4
Sell
-1,800
Closed -$265K 722
2020
Q3
$265K Buy
+1,800
New +$279K 0.02% 505

Other funds holding LLY

Maven Securities's LLY Position: Q2 2025 in Review

Maven Securities sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 4,370 shares — an estimated $3.4M sold.

Maven Securities first reported a position in LLY in Q1 2021 and held it in 13 quarters. The position peaked at $5.28M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Maven Securities reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 4,370 Eli Lilly shares in Q2 2025, an estimated $3.4M.
  • Maven Securities first reported a position in Eli Lilly in Q1 2021 and held it in 13 quarters.
  • Maven Securities's Eli Lilly position peaked at $5.28M in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.